Client Extranet
|
Site Map
|
RSS
About Us
Practices
People
Offices
News & Insights
Careers
Blogger
Delicious
Digg
Facebook
LinkedIn
Twitter
Email
Home
»
People
»
Theodore M Hester
» Matters
Theodore M Hester (Ted)
Partner
WASHINGTON, D.C.
T: +1 202 626 2901
F: +1 202 626 3737
E-mail
CLOSE
[x]
All Offices
Abu Dhabi
Atlanta
Austin
Charlotte
Dubai
Frankfurt
Geneva
Houston
London
Moscow
New York
Paris
Riyadh
San Francisco
Silicon Valley
Singapore
Washington, D.C.
All Practices
Antitrust
Antitrust & IP
Antitrust Counseling
Antitrust Energy
Cartel Litigation
Civil Antitrust Litigation
EU Competition
Healthcare Antitrust
M&A / Joint Ventures
Pharma Antitrust Solutions
UK Competition and Regulatory
Appellate Litigation
Asian Practice
Asset Management
Bankruptcy/Restructuring
Climate Change
Commercial Disputes
Congressional Investigations
Construction and Procurement
Construction Litigation
Consumer Class Action
Copyright
Corporate Espionage & Competitive Intelligence
Corporate Finance
Corporate Governance
Corporate Plaintiffs Litigation
D&O Liability Litigation
Domestic Arbitration/ADR
E-Commerce
E-Discovery
Emerging Growth
Employee Benefits & Executive Compensation
Energy & Natural Resources
Arbitration
Construction and Procurement
Construction Dispute Resolution
Environmental Litigation
Finance
Financial Restructuring
Foreign Corrupt Practices Act
Intellectual Property
LNG
Maritime
Mergers and Acquisitions
Mining and Natural Resources
Nuclear
Oil & Gas
Oil & Gas Exploration and Production
Oil & Gas Litigation
Oil & Gas Midstream and Pipelines
Oil & Gas Oil Field Services
Oil & Gas Refining
Petrochemical
Power
Power Litigation
Private Equity
Project Development
Regulatory
Renewable/Alternative Energy
Tax
Tort Litigation
Environmental
Environmental Litigation
ERISA & Employee Benefits Litigation
FDA & Life Sciences
Financial Markets
Distressed Assets
Financial Markets Policy
Subprime and Capital Markets
Financial Services
Financial Services Litigation
First Amendment/Defamation
Franchise & Distribution
Franchise & Distribution Litigation
German Practice
Government Advocacy & Public Policy
Political Law
Healthcare Industry
Academic Medical Centers
Antitrust
Children’s Health
Civil Litigation
Class Actions
Clinical Research Compliance
Financial Restructuring
Government Advocacy/Public Policy
Government Investigations/FCA
Health Information Privacy & Security
Healthcare M&A
Healthcare Reform Task Force
Information Technology/EHRs
International Healthcare
Labor & Employment
Managed Care, Health Plans and Insurers
Private Equity
Provider Representation
RAC & MIC Audits and Appeals
Regulatory and Compliance
Reimbursement
Tax
Tax Exempt Bond Financings
Healthcare Litigation
Homeland Security
Infrastructure Finance
Insurance Coverage and Recovery
Intellectual Property
International
International Arbitration
International Trade/WTO
Islamic Finance
Arbitration
Asset Finance
Energy
Healthcare
Middle East & North Africa
Petrochemicals and Refining
Power and Water
Private Equity
Private Equity/Investment Funds
Project Finance
Projects and Construction
Real Estate
Saudi Arabia Practice
Joint Ventures / Strategic Alliances
Labor & Employment
Latin America Practice
Licensing
Marketing & Advertising Litigation
Mass Tort
Mergers & Acquisitions
Our Approach to Litigation
Outsourcing
Patents
Pharma/Biotech/Med Devices
Antitrust
Business Litigation
Corporate
Emerging Companies
Government Advocacy
Government Investigations
Intellectual Property
International Arbitration
Labor & Employment
Products Liability/Mass Tort
Privacy & Information Security
Private Equity/Investment Funds
Private Finance
Product Liability Litigation
Professional Liability Litigation
Project & Equipment Finance
Public Finance
Real Estate
Russia Practice
Securities Litigation/D&O Liability
Special Matters/Government Investigations
Sports, Media & Entertainment
Tax
Tax Litigation
Tax-Exempt
Technology Transactions
Telecommunications
Toxic Tort Litigation
Trade Secrets & Non-Compete Litigation
Trademarks/False Advertising
Advanced Search
Profile
|
Matters
|
Recognition
|
News & Insights
Representative Experience
Representing Toyota in investigations and hearings by the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, and the Senate Commerce, Science and Transportation Committee relating to allegations of unintended acceleration.
Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the pharmaceutical, medical device, food processing, healthcare, telecommunications, logistics, insurance and oil industries.
Representing major pharmaceutical and medical device companies before the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, the Senate Finance Committee, and the Senate Aging Committee in connection with investigations relating to the interaction of these companies with the FDA in the drug and device approval process, the disclosure by those companies of clinical trial data, their release of product performance data, their marketing practices, including drug pricing issues, off label use, direct-to-consumer advertising, and sampling programs, and their relationships with physicians, professional organizations and academic institutions.
Representing the Georgia Department of Agriculture in an investigation relating to the presence of salmonella in peanut butter.
Representing a multinational manufacturer in an Oversight and Investigations Subcommittee investigation relating to the safety of infant formula.
Representing a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.
Representing a global consulting firm in connection with an Oversight and Government Reform Committee investigation of executive compensation practices, and a House Financial Services Committee hearing on federal oversight of insurance.
Representing a health insurer in a Senate Commerce Committee investigation of out-of-network coverage.
Representing a major government contractor in connection with investigations of conflicts of interest at the National Institutes of Health by the House Energy and Commerce Committee and the Inspector General of the Department of Health and Human Services.
Representing a healthcare products manufacturer in connection with an investigation of active pharmaceutical ingredients imported from China.
Representing a beverage manufacturer in an Oversight and Investigations Subcommittee inquiry relating to chemical or microbiological contamination.
Representing a Medicare insurance company in connection with a request for information from the House Energy and Commerce Committee and the Senate Aging Committee regarding marketing practices in the Medicare Advantage program.
Representing a nationwide retail grocery chain in an Oversight and Investigations Subcommittee investigation of meat packaging.
Representing a medical device manufacturer in investigations relating to the use of its products in V.A. hospitals by both the House and Senate Veterans’ Affairs Committees.
Represented a property casualty insurance company in connection with a House Financial Services Committee investigation about insurance coverage issues growing out of losses sustained from Hurricane Katrina.
Represented a major parcel carrier before the House Energy and Commerce Committee and the Senate’s Permanent Subcommittee on Investigations relating to the shipment of counterfeit or unsafe pharmaceuticals ordered over the internet.
Represented Purdue Pharma in connection with five separate congressional hearings and a two-year investigation by the Government Accountability Office on the abuse and diversion of the company's pain medication, OxyContin®.
Represented Bridgestone/Firestone, Inc. in connection with congressional investigations into rollover accidents by both the House Energy and Commerce Committee and the Senate Commerce, Science, and Transportation Committee.
Represented the Independent Review Committee of the Statue of Liberty-Ellis Island Foundation in connection with investigations of the Foundation and the National Park Service by the Senate Finance Committee and the Department of the Interior Inspector General.
Represented The SCOOTER Store, Ltd. in a Senate Finance Committee investigation of Medicare reimbursement of motorized wheelchairs.
Represented Metabolife International before the Government Accountability Office during its investigation into the company's health-related call records regarding its dietary supplement, Metabolife 356, and before the House Energy and Commerce Committee in its investigation of dietary supplements containing ephedra.
Represented the Georgia Amateur Athletic Foundation, the entity that organized Atlanta's bid for the 1996 Summer Olympic Games, before the House Energy and Commerce Committee in an investigation focused on the Olympic bid process.
Represented the nation's leading supplier of flu vaccine to health care providers in an investigation relating to the distribution of flu vaccine.
Coordinated preparation of the July 2000 report issued by the Nunn-Wolfowitz Task Force, led by former Senator Sam Nunn and then-Ambassador Paul Wolfowitz. In the wake of congressional investigations into allegations that space launch technology was improperly transferred by certain U.S. companies to China, the Task Force was commissioned by the Board of Directors of Hughes Electronics to help review and strengthen the company's export compliance program. The Nunn-Wolfowitz report recommended industry "best practices" guidelines regarding export compliance programs.
PRACTICE AREAS
Climate Change
Congressional Investigations
Distressed Assets
Energy & Natural Resources
Financial Markets Policy
Government Advocacy &
Public Policy
Health Government Advocacy
Healthcare Industry
Pharma Government Advocacy & Public Policy
Pharma Government Investigations
EDUCATION
J.D., Harvard University
A.B.,
magna cum laude
, University of Georgia
ADMISSIONS
Georgia
Washington, D.C.